Alerts will be sent to your verified email
Verify Email
TRABI
|
Transgene Biotek
|
Global Longlife Hosp
|
Dr Lalchandani Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-34.5 % | 6.24 % | 2.53 % |
|
5yr average Equity Multiplier
|
11.14 | 1.57 | 1.69 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.54 | 0.43 |
|
5yr Avg Net Profit Margin
|
-5919.21 % | 8.63 % | 1.96 % |
|
Price to Book
|
1.85 | 0.56 | 1.41 |
|
P/E
|
0.0 | 77.31 | 34.71 |
|
5yr Avg Cash Conversion Cycle
|
59.29 Days | -351.43 Days | 103.23 Days |
|
Inventory Days
|
166.26 Days | 11.26 Days | 78.71 Days |
|
Days Receivable
|
11.76 Days | 716.69 Days | 408.23 Days |
|
Days Payable
|
259.7 Days | 489.79 Days | 262.63 Days |
|
5yr Average Interest Coverage Ratio
|
-19.2 | 2.59 | 3.16 |
|
5yr Avg ROCE
|
-3.86 % | 12.16 % | 5.08 % |
|
5yr Avg Operating Profit Margin
|
-527.18 % | -132.06 % | 14.13 % |
|
5 yr average Debt to Equity
|
1.02 | 0.48 | 0.48 |
|
5yr CAGR Net Profit
|
-42.08 % | -37.22 % | -16.1 % |
|
5yr Average Return on Assets
|
-3.77 % | 3.07 % | 1.95 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
23.64 % | 35.44 % | 31.15 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -18.85 % | -29.63 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Transgene Biotek
|
Global Longlife Hosp
|
Dr Lalchandani Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|